Playback speed
10 seconds
ASCO 2022: Dabrafenib + Trametinib Significantly Increases Overall Response Rate in Pediatric Low-Grade Gliomas
By
ecancer
FEATURING
Eric Bouffet
By
ecancer
FEATURING
Eric Bouffet
69 views
June 24, 2022
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY